These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23561850)

  • 1. Frameshift-derived neoantigens constitute immunotherapeutic targets for patients with microsatellite-instable haematological malignancies: frameshift peptides for treating MSI+ blood cancers.
    Maletzki C; Schmidt F; Dirks WG; Schmitt M; Linnebacher M
    Eur J Cancer; 2013 Jul; 49(11):2587-95. PubMed ID: 23561850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenic peptides generated by frameshift mutations in DNA mismatch repair-deficient cancer cells.
    Schwitalle Y; Linnebacher M; Ripberger E; Gebert J; von Knebel Doeberitz M
    Cancer Immun; 2004 Nov; 4():14. PubMed ID: 15563124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An MSI tumor specific frameshift mutation in a coding microsatellite of MSH3 encodes for HLA-A0201-restricted CD8+ cytotoxic T cell epitopes.
    Garbe Y; Maletzki C; Linnebacher M
    PLoS One; 2011; 6(11):e26517. PubMed ID: 22110587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite Instability.
    Leoni G; D'Alise AM; Cotugno G; Langone F; Garzia I; De Lucia M; Fichera I; Vitale R; Bignone V; Tucci FG; Mori F; Leuzzi A; Di Matteo E; Troise F; Abbate A; Merone R; Ruzza V; Diodoro MG; Yadav M; Gordon-Alonso M; Vanhaver C; Panigada M; Soprana E; Siccardi A; Folgori A; Colloca S; van der Bruggen P; Nicosia A; Lahm A; Catanese MT; Scarselli E
    Cancer Res; 2020 Sep; 80(18):3972-3982. PubMed ID: 32690723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers.
    Schwitalle Y; Kloor M; Eiermann S; Linnebacher M; Kienle P; Knaebel HP; Tariverdian M; Benner A; von Knebel Doeberitz M
    Gastroenterology; 2008 Apr; 134(4):988-97. PubMed ID: 18395080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
    Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
    Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum antibodies against frameshift peptides in microsatellite unstable colorectal cancer patients with Lynch syndrome.
    Reuschenbach M; Kloor M; Morak M; Wentzensen N; Germann A; Garbe Y; Tariverdian M; Findeisen P; Neumaier M; Holinski-Feder E; von Knebel Doeberitz M
    Fam Cancer; 2010 Jun; 9(2):173-9. PubMed ID: 19957108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse Model.
    Gebert J; Gelincik O; Oezcan-Wahlbrink M; Marshall JD; Hernandez-Sanchez A; Urban K; Long M; Cortes E; Tosti E; Katzenmaier EM; Song Y; Elsaadi A; Deng N; Vilar E; Fuchs V; Nelius N; Yuan YP; Ahadova A; Sei S; Shoemaker RH; Umar A; Wei L; Liu S; Bork P; Edelmann W; von Knebel Doeberitz M; Lipkin SM; Kloor M
    Gastroenterology; 2021 Oct; 161(4):1288-1302.e13. PubMed ID: 34224739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frameshift peptide-derived T-cell epitopes: a source of novel tumor-specific antigens.
    Linnebacher M; Gebert J; Rudy W; Woerner S; Yuan YP; Bork P; von Knebel Doeberitz M
    Int J Cancer; 2001 Jul; 93(1):6-11. PubMed ID: 11391614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chk1 frameshift mutation in sporadic and hereditary non-polyposis colorectal cancers with microsatellite instability.
    Kim CJ; Lee JH; Song JW; Cho YG; Kim SY; Nam SW; Yoo NJ; Park WS; Lee JY
    Eur J Surg Oncol; 2007 Jun; 33(5):580-5. PubMed ID: 17408908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunities for immunotherapy in microsatellite instable colorectal cancer.
    Westdorp H; Fennemann FL; Weren RD; Bisseling TM; Ligtenberg MJ; Figdor CG; Schreibelt G; Hoogerbrugge N; Wimmers F; de Vries IJ
    Cancer Immunol Immunother; 2016 Oct; 65(10):1249-59. PubMed ID: 27060000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
    Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
    Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A ten markers panel provides a more accurate and complete microsatellite instability analysis in mismatch repair-deficient colorectal tumors.
    Agostini M; Enzo MV; Morandi L; Bedin C; Pizzini S; Mason S; Bertorelle R; Urso E; Mescoli C; Lise M; Pucciarelli S; Nitti D
    Cancer Biomark; 2010; 6(1):49-61. PubMed ID: 20164541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell responses against microsatellite instability-induced frameshift peptides and influence of regulatory T cells in colorectal cancer.
    Bauer K; Nelius N; Reuschenbach M; Koch M; Weitz J; Steinert G; Kopitz J; Beckhove P; Tariverdian M; von Knebel Doeberitz M; Kloor M
    Cancer Immunol Immunother; 2013 Jan; 62(1):27-37. PubMed ID: 22729559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-specific immunological recognition of frameshift-mutated peptides in colon cancer with microsatellite instability.
    Ishikawa T; Fujita T; Suzuki Y; Okabe S; Yuasa Y; Iwai T; Kawakami Y
    Cancer Res; 2003 Sep; 63(17):5564-72. PubMed ID: 14500396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms.
    Borie C; Colas C; Dartigues P; Lazure T; Rince P; Buhard O; Folliot P; Chalastanis A; Muleris M; Hamelin R; Mercier D; Oliveira C; Seruca R; Chadburn A; Leblond V; Barete S; Gaïdano G; Martin A; Gaulard P; Fléjou JF; Raphael M; Duval A
    Int J Cancer; 2009 Nov; 125(10):2360-6. PubMed ID: 19551857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsatellite instability is not an uncommon finding in adult de novo acute myeloid leukemia.
    Nomdedéu JF; Perea G; Estivill C; Lasa A; Carnicer MJ; Brunet S; Aventín A; Sierra J
    Ann Hematol; 2005 Jun; 84(6):368-75. PubMed ID: 15789228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an MSI-H tumor-specific cytotoxic T cell epitope generated by the (-1) frame of U79260(FTO).
    Linnebacher M; Wienck A; Boeck I; Klar E
    J Biomed Biotechnol; 2010; 2010():841451. PubMed ID: 20339516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct clinicopathologic and genetic profiles in sporadic gastric cancer with different mutator phenotypes.
    Wu MS; Lee CW; Shun CT; Wang HP; Lee WJ; Chang MC; Sheu JC; Lin JT
    Genes Chromosomes Cancer; 2000 Apr; 27(4):403-11. PubMed ID: 10719371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A TGF betaRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8+ T cells.
    Saeterdal I; Gjertsen MK; Straten P; Eriksen JA; Gaudernack G
    Cancer Immunol Immunother; 2001 Nov; 50(9):469-76. PubMed ID: 11761441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.